Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

This grant program supports research aimed at developing innovative products and services to prevent and treat Alzheimer's disease and AD-related dementias. It encourages advancements in care and treatment for patients with these conditions through the National Institute on Aging's Small Business Technology Transfer Research (STTR) program.

Eligibility

Organization's Location
USA
Program Location
USA
Organization Type
not specified

Submission

Visit Apply for more information.

Similar grants

up to 650k
Due 10/18 and 11/18
Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) (345099)
US Department of Health & Human Services: National Institutes of Health (NIH)
Alzheimer's disease and other forms of dementia
not specified
Due 10/5 and 11/5
Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (345098)
US Department of Health & Human Services: National Institutes of Health (NIH)
Alzheimer's disease and other forms of dementia
not specified
Due 1/5/25 and 4/5/25
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
US Department of Health & Human Services: National Institutes of Health (NIH)
Alzheimer's disease and other forms of dementia
not specified
Due 10/5 and 11/5
Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)(U01 Clinical Trial Optional)
US Department of Health & Human Services: National Institutes of Health (NIH)
Alzheimer's disease and other forms of dementia
up to 275k
Due 10/16 and 11/16
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) (348713)
US Department of Health & Human Services: National Institutes of Health (NIH)
Alzheimer's disease and other forms of dementia
not specified
Due 10/5 and 2/5/25
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) (348712)
US Department of Health & Human Services: National Institutes of Health (NIH)
Alzheimer's disease and other forms of dementia
up to 2.5M
Due 10/4
Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 - Clinical Trial Not Allowed)
US Department of Health & Human Services: National Institutes of Health (NIH)
Alzheimer's disease and other forms of dementia
up to 1M
Rolling
Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)
Alzheimer's Association
Alzheimer's disease and other forms of dementia
up to 2.5M
Due 10/4
Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed) (352214)
US Department of Health & Human Services: National Institutes of Health (NIH)
Neurology
Genetic research
Alzheimer's disease and other forms of dementia
not specified
Due 10/21 and 11/21
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
US Department of Health & Human Services: National Institutes of Health (NIH)
Alzheimer's disease and other forms of dementia